Literature DB >> 22031946

Viral expression directs the fate of B cells in bovine leukemia virus-infected sheep.

Arnaud Florins1, Alix de Brogniez, Marjet Elemans, Amel-Baya Bouzar, Carole François, Michal Reichert, Becca Asquith, Luc Willems.   

Abstract

The host immune response is believed to tightly control viral replication of deltaretroviruses such as human T-lymphotropic virus type 1 (HTLV-1) and bovine leukemia virus (BLV). However, this assumption has not been definitely proven in vivo. In order to further evaluate the importance of the immune response in the BLV model, we studied the fate of cells in which viral expression was transiently induced. Using a dual fluorochrome labeling approach, we showed that ex vivo induction of viral expression induces higher death rates of B cells in vivo. Furthermore, cyclosporine treatment of these animals indicated that an efficient immune response is required to control virus-expressing cells.

Entities:  

Mesh:

Year:  2011        PMID: 22031946      PMCID: PMC3255919          DOI: 10.1128/JVI.05718-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes.

Authors:  E Hanon; S Hall; G P Taylor; M Saito; R Davis; Y Tanaka; K Usuku; M Osame; J N Weber; C R Bangham
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

2.  Quantifying lymphocyte kinetics in vivo using carboxyfluorescein diacetate succinimidyl ester (CFSE).

Authors:  Becca Asquith; Christophe Debacq; Arnaud Florins; Nicolas Gillet; Teresa Sanchez-Alcaraz; Angelina Mosley; Luc Willems
Journal:  Proc Biol Sci       Date:  2006-05-07       Impact factor: 5.349

3.  Expression of the bovine leukemia virus and its internal antigen in blood lymphocytes.

Authors:  V Baliga; J F Ferrer
Journal:  Proc Soc Exp Biol Med       Date:  1977-11

4.  Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo.

Authors:  Amine Achachi; Arnaud Florins; Nicolas Gillet; Christophe Debacq; Patrice Urbain; Germain Manfouo Foutsop; Fabian Vandermeers; Agnieszka Jasik; Michal Reichert; Pierre Kerkhofs; Laurence Lagneaux; Arsène Burny; Richard Kettmann; Luc Willems
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

5.  Fate of premalignant clones during the asymptomatic phase preceding lymphoid malignancy.

Authors:  Vincent Moulés; Carole Pomier; David Sibon; Anne-Sophie Gabet; Michal Reichert; Pierre Kerkhofs; Luc Willems; Franck Mortreux; Eric Wattel
Journal:  Cancer Res       Date:  2005-02-15       Impact factor: 12.701

6.  Transcriptional activation of bovine leukemia virus in blood cells from experimentally infected, asymptomatic sheep with latent infections.

Authors:  D M Lagarias; K Radke
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

7.  Cyclosporine-induced immune suppression alters establishment of HTLV-1 infection in a rabbit model.

Authors:  Rashade A H Haynes; Evan Ware; Christopher Premanandan; Bevin Zimmerman; Lianbo Yu; Andrew J Phipps; Michael D Lairmore
Journal:  Blood       Date:  2009-11-20       Impact factor: 22.113

8.  Human T-cell leukemia virus (HTLV-I) transcripts in fresh and cultured cells of patients with adult T-cell leukemia.

Authors:  G Franchini; F Wong-Staal; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

9.  In vivo infection of sheep by bovine leukemia virus mutants.

Authors:  L Willems; R Kettmann; F Dequiedt; D Portetelle; V Vonèche; I Cornil; P Kerkhofs; A Burny; M Mammerickx
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

Review 10.  Mechanisms of HTLV-1 persistence and transformation.

Authors:  M Boxus; L Willems
Journal:  Br J Cancer       Date:  2009-09-29       Impact factor: 7.640

View more
  12 in total

1.  Proteome analysis of sheep B lymphocytes in the course of bovine leukemia virus-induced leukemia.

Authors:  Michal Reichert
Journal:  Exp Biol Med (Maywood)       Date:  2017-04-24

Review 2.  Integration site and clonal expansion in human chronic retroviral infection and gene therapy.

Authors:  Heather A Niederer; Charles R M Bangham
Journal:  Viruses       Date:  2014-10-31       Impact factor: 5.048

3.  Chemoresistance to Valproate Treatment of Bovine Leukemia Virus-Infected Sheep; Identification of Improved HDAC Inhibitors.

Authors:  Nicolas Gillet; Fabian Vandermeers; Alix de Brogniez; Arnaud Florins; Annamaria Nigro; Carole François; Amel-Baya Bouzar; Olivier Verlaeten; Eric Stern; Didier M Lambert; Johan Wouters; Luc Willems
Journal:  Pathogens       Date:  2012-10-08

4.  Ablation of non-coding RNAs affects bovine leukemia virus B lymphocyte proliferation and abrogates oncogenesis.

Authors:  Roghaiyeh Safari; Jean-Rock Jacques; Yves Brostaux; Luc Willems
Journal:  PLoS Pathog       Date:  2020-05-14       Impact factor: 6.823

Review 5.  Recent Advances in BLV Research.

Authors:  Pierre-Yves Barez; Alix de Brogniez; Alexandre Carpentier; Hélène Gazon; Nicolas Gillet; Gerónimo Gutiérrez; Malik Hamaidia; Jean-Rock Jacques; Srikanth Perike; Sathya Neelature Sriramareddy; Nathalie Renotte; Bernard Staumont; Michal Reichert; Karina Trono; Luc Willems
Journal:  Viruses       Date:  2015-11-24       Impact factor: 5.048

6.  Massive depletion of bovine leukemia virus proviral clones located in genomic transcriptionally active sites during primary infection.

Authors:  Nicolas A Gillet; Gerónimo Gutiérrez; Sabrina M Rodriguez; Alix de Brogniez; Nathalie Renotte; Irene Alvarez; Karina Trono; Luc Willems
Journal:  PLoS Pathog       Date:  2013-10-03       Impact factor: 6.823

7.  MicroRNAs Encoded by Bovine Leukemia Virus (BLV) Are Associated with Reduced Expression of B Cell Transcriptional Regulators in Dairy Cattle Naturally Infected with BLV.

Authors:  Meredith C Frie; Casey J Droscha; Ashley E Greenlick; Paul M Coussens
Journal:  Front Vet Sci       Date:  2018-01-15

8.  How Does HTLV-1 Undergo Oncogene-Dependent Replication Despite a Strong Immune Response?

Authors:  Hélène Gazon; Pradeep Chauhan; Malik Hamaidia; Clotilde Hoyos; Lin Li; Roghaiyeh Safari; Luc Willems
Journal:  Front Microbiol       Date:  2018-01-15       Impact factor: 5.640

Review 9.  Regulation of Expression and Latency in BLV and HTLV.

Authors:  Aneta Pluta; Juan P Jaworski; Renée N Douville
Journal:  Viruses       Date:  2020-09-25       Impact factor: 5.048

10.  Rates of CTL killing in persistent viral infection in vivo.

Authors:  Marjet Elemans; Arnaud Florins; Luc Willems; Becca Asquith
Journal:  PLoS Comput Biol       Date:  2014-04-03       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.